產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-phospho-IRS1 (Ser312)抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-phospho-IRS1 (Ser312)抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-phospho-IRS1 (Ser312)
Cat. Number:
Anti-phospho-IRS1 (Ser312)抗體KL-5396R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Insulin receptor substrates (IRS) are responsible for several insulin related activities, such as glucose homeostasis, cell growth, cell transformation, apoptosis and insulin signal transduction. Serine/threonine phosphorylation of IRS1 has been demonstrated to be a negative regulator of insulin signaling and is responsible forAnti-phospho-IRS1 (Ser312)抗體 its degradation, although IRS1 degradation pathways are not well understood. IRS1 has also been shown to be constitutively activated in cancers such as breast cancer, Wilm's tumors, and adrenal cortical carcinomas, thus making IRS1 phosphorylation and subsequent degradation an attractive therapeutic target. To date there have been four subtypes identified: IRS1, 2, 3 and 4, with IRS1 being widely expressed.
Also known as:
IRS1 (phospho S312); IRS-1Anti-phospho-IRS1 (Ser312)抗體 (Phospho-Ser312); p-IRS1; IRS1(phospho-Ser789); HIRS 1; HIRS1; Insulin Receptor Substrate 1; IRS-1; IRS 1; IRS1; OTTHUMP00000164234; IRS1_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human.
●
Predicted Molecular Weight: 132kDa.Anti-phospho-IRS1 (Ser312)抗體
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-phospho-IRS1 (Ser312)抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-phospho-IRS1 (Ser312)抗體
Optimal working dilutions must be determined by the end user.
kl601Mu02 B-**細(xì)胞趨化因子1(BLC1)多克隆抗體 Polyclonal Antibody to B-Lymphocyte Chemoattractant 1 (BLC1)
kl603Ra01 生長(zhǎng)調(diào)節(jié)致癌基因β(GROβ)多克隆抗體 Polyclonal Antibody to Growth Regulated Oncogene Beta (GROb)
kl604Ra01 生長(zhǎng)調(diào)節(jié)致癌基因γ(GROγ)多克隆抗體 Polyclonal Antibody to Growth Regulated Oncogene Gamma (GROg)
kl607Mu02 胸腎表達(dá)趨化因子(BRAK)多克隆抗體 Polyclonal Antibody to Breast And Kidney Expressed Chemokine (BRAK)
kl607Ra01 胸腎表達(dá)趨化因子(BRAK)多克隆抗體 Polyclonal Antibody to Breast And Kidney Expressed Chemokine (BRAK)
kl613Mu02 凝血因子ⅩⅢB肽(F13B)多克隆抗體 Polyclonal Antibody to Coagulation Factor XIII B Polypeptide (F13B)
kl617Hu01 GDP解離抑制因子1(GDI1)多克隆抗體 Polyclonal Antibody to GDP Dissociation Inhibitor 1 (GDI1)
kl626Mu02 白介素10受體α(IL10Rα)多克隆抗體 Polyclonal Antibody to Interleukin 10 Receptor Alpha (IL10Ra)
kl635Ra01 葡萄糖轉(zhuǎn)運(yùn)蛋白3(GLUT3)多克隆抗體 Polyclonal Antibody to Glucose Transporter 3 (GLUT3)
kl636Hu01 肽基脯氨酰異構(gòu)酶C(PPIC)多克隆抗體 Polyclonal Antibody to Peptidylprolyl Isomerase C (PPIC)
kl640Mu01 前列腺素D合酶(PTGDS)多克隆抗體 Polyclonal Antibody to Prostaglandin D2 Synthase, Hematopoietic (PTGDS)
kl640Mu02 前列腺素D合酶(PTGDS)多克隆抗體 Polyclonal Antibody to Prostaglandin D2 Synthase, Hematopoietic (PTGDS)
kl642Hu01 電子轉(zhuǎn)移黃素蛋白β肽(ETFβ)多克隆抗體 Polyclonal Antibody to Electron Transfer Flavoprotein Beta Polypeptide (ETFb)
kl643Mu02 白介素13受體α2(IL13Rα2)多克隆抗體 Polyclonal Antibody to Interleukin 13 Receptor Alpha 2 (IL13Ra2)
kl647Mu02 趨化因子C-C-基元受體7(CCR7)多克隆抗體 Polyclonal Antibody to Chemokine C-C-Motif Receptor 7 (CCR7)
kl648Ra01 煙堿型膽堿受體β1(CHRNβ1)多克隆抗體 Polyclonal Antibody to Cholinergic Receptor, Nicotinic, Beta 1 (CHRNb1)
kl653Mu02 肌肉生長(zhǎng)抑制素(MSTN)多克隆抗體 Polyclonal Antibody to Myostatin (MSTN)
kl653Po01 肌肉生長(zhǎng)抑制素(MSTN)多克隆抗體 Polyclonal Antibody to Myostatin (MSTN)
kl659Mu01 胰島素樣生長(zhǎng)因子1受體(IGF1R)多克隆抗體 Polyclonal Antibody to Insulin Like Growth Factor 1 Receptor (IGF1R)
